FF
FFO1.F Fufeng Group Limited
- Market cap
- EUR 1.12B
- P/E
- 8.9x
- P/B
- 0.43x
- ROE
- 12.7%
- Dividend yield
- 2.83%
- Fundamental score
- -
Ratios use the latest price and the fiscal year ending Dec 2025.
Is FFO1.F undervalued?
Graham numberFFO1.F trades 58.6% below its Graham number.
Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?
Fufeng Group Limited fundamental analysis
No fundamental analysis for Fufeng Group Limited yet.
Fufeng Group Limited stock price
Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.
About Fufeng Group Limited
Fufeng Group Limited, an investment holding company, engages in the manufacture and sale of fermentation-based food additives, and biochemical and starch-based products in the People's Republic of China and internationally. It operates through five segments: Food Additives, Animal Nutrition, High-End Amino Acid, Colloid, and Others. The Food Additives segment offers monosodium glutamate, starch sweeteners, glutamic acid, compound seasoning, and corn oil. The Animal Nutrition…
Full company profileFufeng Group Limited financial statements
Fufeng Group Limited annual financial statements (CNY; K = thousand, M = million, B = billion, T = trillion)
| Item | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Income Statement | ||||||||||
| Revenue | 11.8B | 13.0B | 13.8B | 16.2B | 16.7B | 21.5B | 27.5B | 28.0B | 27.8B | 27.9B |
| Gross Profit | 2.41B | 2.98B | 2.57B | 3.26B | 2.82B | 3.91B | 7.21B | 6.25B | 5.06B | 5.48B |
| Operating Income | 1.41B | 1.75B | 1.09B | 1.52B | 975M | 1.76B | 4.63B | 3.49B | 2.24B | 2.50B |
| EBITDA | - | 2.66B | 3.44B | 2.76B | 977M | 2.93B | 6.26B | 5.14B | 4.25B | 4.56B |
| Net Income | 1.09B | 1.38B | 1.85B | 1.14B | 630M | 1.28B | 3.86B | 3.14B | 2.31B | 2.47B |
| EPS | - | 0.54 | 0.72 | 0.45 | 0.25 | 0.51 | 1.52 | 1.25 | 0.92 | 0.98 |
| Balance Sheet | ||||||||||
| Total Assets | 14.5B | 16.0B | 20.3B | 19.5B | 19.4B | 21.5B | 26.4B | 32.6B | 36.1B | 43.7B |
| Total Liabilities | 7.64B | 6.51B | 9.33B | 8.08B | 7.67B | 8.83B | 10.9B | 15.2B | 17.7B | 24.3B |
| Shareholders' Equity | 6.82B | 9.46B | 11.0B | 11.4B | 11.7B | 12.7B | 15.5B | 17.3B | 18.3B | 19.5B |
| Cash & Short-term Investments | 960M | 419M | 1.73B | 1.83B | 1.23B | 3.54B | 7.01B | 2.83B | 9.90B | 13.5B |
| Cash Flow | ||||||||||
| Operating Cash Flow | 2.09B | 1.20B | 1.51B | 892M | 206M | 2.77B | 3.60B | 1.70B | 2.96B | 2.91B |
| Capital Expenditure | 1.40B | 1.97B | 1.72B | 1.63B | 989M | 498M | 988M | 2.32B | 1.22B | 2.67B |
| Free Cash Flow | - | -786M | -343M | -754M | -799M | 2.23B | 2.57B | -619M | 1.73B | 241M |
| Ratios | ||||||||||
| ROE | 16.0% | 14.6% | 16.8% | 10.0% | 5.4% | 10.1% | 24.9% | 18.1% | 12.6% | 12.7% |
| ROA | 7.6% | 8.7% | 9.1% | 5.8% | 3.3% | 6.0% | 14.6% | 9.7% | 6.4% | 5.6% |
| Net Profit Margin | 9.3% | 10.6% | 13.4% | 7.0% | 3.8% | 5.9% | 14.1% | 11.2% | 8.3% | 8.8% |
What these items mean
- Revenue
- Total sales of goods and services in the period.
- Gross Profit
- Revenue minus the direct cost of producing what was sold.
- Operating Income
- Profit from the core business after operating expenses.
- EBITDA
- Earnings before interest, taxes, depreciation and amortization.
- Net Income
- Profit left for shareholders after all expenses, interest and taxes.
- EPS
- Net income divided by shares outstanding.
- Total Assets
- Everything the company owns.
- Total Liabilities
- Everything the company owes.
- Shareholders' Equity
- Assets minus liabilities: the book value that belongs to shareholders.
- Cash & Short-term Investments
- Cash and investments that can be turned into cash quickly.
- Operating Cash Flow
- Cash generated by the core business.
- Capital Expenditure
- Cash spent on property, plant and equipment.
- Free Cash Flow
- Operating cash flow minus capital expenditure: cash left for dividends, buybacks or debt repayment.
- ROE
- Return on equity: net income divided by shareholders' equity.
- ROA
- Return on assets: net income divided by total assets.
- Net Profit Margin
- Net income as a share of revenue.
Fufeng Group Limited dividends
- Dividend yield
- 2.83%
- Forward dividend
- 0.01 EUR
- Payout ratio
- 54.4%
- Ex-dividend date
- Sep 9, 2026
| Fiscal year | Dividends paid | Per share | Payout ratio |
|---|---|---|---|
| 2025 | CNY 1.34B | 0.54 | 54.4% |
| 2024 | CNY 1.22B | 0.48 | 52.7% |
| 2023 | CNY 1.28B | 0.51 | 40.8% |
| 2022 | CNY 1.08B | 0.43 | 28.0% |
| 2021 | CNY 293M | 0.12 | 22.9% |
| 2020 | CNY 317M | 0.13 | 50.3% |
| 2019 | EUR 735M | 0.29 | 64.6% |
| 2018 | EUR 320M | 0.13 | 17.3% |
| 2017 | EUR 368M | 0.14 | 26.6% |
| 2016 | EUR 92.5M | - | 8.5% |
From the cash flow statement: dividends paid in the fiscal year, divided by that year's shares outstanding. Payout ratio = dividends paid / net income.
Who owns Fufeng Group Limited
- Insiders 41.30%
- Institutions 7.23%
- Public & others 51.47%
- Shares outstanding 2.51B
- Free float 1.21B
Fufeng Group Limited company profile
- Company name
- Fufeng Group Limited
- Ticker
- FFO1.F
- ISIN
- KYG368441195
- Exchange
- Frankfurt Exchange
- Sector
- Basic Materials
- Industry
- Chemicals
- Employees
- 17,500
- Fiscal year end
- December
- Address
- Building 4, Qingdao, China, 266114
- Phone
- 86 32 5828 3718
- Website
- fufeng-group.com
About Fufeng Group Limited
Fufeng Group Limited, an investment holding company, engages in the manufacture and sale of fermentation-based food additives, and biochemical and starch-based products in the People's Republic of China and internationally. It operates through five segments: Food Additives, Animal Nutrition, High-End Amino Acid, Colloid, and Others. The Food Additives segment offers monosodium glutamate, starch sweeteners, glutamic acid, compound seasoning, and corn oil. The Animal Nutrition segment provides animal nutrition products, including refined corn products, threonine, and lysine. The High-End Amino Acid segment offers high-end amino acid products. The Colloid segment provides xanthan and gellan gum products. The Other segment offers fertilizers, synthetic ammonia, pharmaceuticals, and other products. It also engages in the manufacture and sale of autoclaved aerated concrete blocks; research and development, promotion, and industrialisation of new biological techniques and achievements; information services of biological technique; sale of cosmetics and biological products; provision of logistics and heating services; and imports and distributes alcoholic beverage products. The company was founded in 1999 and is based in Qingdao, the People's Republic of China.
Fufeng Group Limited management
4- Mr. Xuechun LiPrincipal Founder & Executive Chairman · born 1951
- Mr. Deheng LiCo-CEO & Executive Director · born 1968
- Mr. Guangyu LiCo-CEO & Executive Director · born 1978
- Mr. Wing Yiu Yau AHKSA, FCCACFO & Company Secretary · born 1968